background parasite disease malaria remain major global public health concern truly effect vaccine exist one approach develop target sex blood stage result clinic symptom attempt fail new antigen pa p emerge potent candid multiple studi demons immunogen better correct protect present particular delivery system system selfassembl protein nanoparticles span reli coiledcoil domain protein form stable nanoparticles past use de novo design amino acid drive format scaffold present antigen editor partial surface use natur occur found tex scaffold thu engine extend domain onto n c terminus mono develop effect display single use sequence scaffold partial marin model induce immune response similar one observe seroposit individual ended region concur demons ppasapn response akin burkina faso since highly conserve among differ plasmodium spec novel span may even provide crossprotect falciparum viva two human pathogen also east manufacture store deli popup need without complex provide low cost 